Therapeutic Class
BMS $30bn CAR-T vision boosted by MA plant approval
Therapeutic Class
BMS $30bn CAR-T vision boosted by MA plant approvalBMS $30bn CAR-T vision boosted by MA plant approval
The US FDA has approved a 244,000 square-foot manufacturing plant in Devens, bringing a third CAR-T facility online for BMS.
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.